Azam Roohi, Mina Tabrizi, Mehdi Yaseri, Fereshteh Mir Mohammadrezaei, Behrouz Nikbin
{"title":"健康成人LDL-C与血清IL-17A水平呈负相关","authors":"Azam Roohi, Mina Tabrizi, Mehdi Yaseri, Fereshteh Mir Mohammadrezaei, Behrouz Nikbin","doi":"10.2174/2213988501812010001","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hypercholesterolemia is a modifiable risk factor in atherosclerosis with a complex association with inflammation.</p><p><strong>Objective: </strong>In the present study, the association between low-density lipoprotein cholesterol (LDL-C) and interleukin 17A (IL-17A), as an inflammatory cytokine, was investigated. In addition to IL-17A, serum levels of interleukin 23 (IL-23) and transforming growth factor β (TGF-β), as effective cytokines in T helper 17 cell (Th17) development, were also determined.</p><p><strong>Method: </strong>Cytokine levels were measured using enzyme-linked immunosorbent assay (ELISA) in healthy subjects with LDL-C<130 versus LDL-C=>130 mg/dL.</p><p><strong>Results: </strong>Although IL-17A is an inflammatory cytokine and a positive association between its levels and LDL-C is expected, the data obtained in this study provide support for a reverse association (<i>p</i><0.05).</p><p><strong>Conclusion: </strong>Inflammation plays a major role in atherosclerosis development; however, various inflammatory components involved in atherosclerosis assert their own unique association with hypercholesterolemia.</p>","PeriodicalId":10755,"journal":{"name":"Current Chemical Genomics and Translational Medicine","volume":"12 ","pages":"1-8"},"PeriodicalIF":0.0000,"publicationDate":"2018-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047196/pdf/","citationCount":"2","resultStr":"{\"title\":\"Healthy Adult LDL-C Bears Reverse Association with Serum IL-17A Levels.\",\"authors\":\"Azam Roohi, Mina Tabrizi, Mehdi Yaseri, Fereshteh Mir Mohammadrezaei, Behrouz Nikbin\",\"doi\":\"10.2174/2213988501812010001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Hypercholesterolemia is a modifiable risk factor in atherosclerosis with a complex association with inflammation.</p><p><strong>Objective: </strong>In the present study, the association between low-density lipoprotein cholesterol (LDL-C) and interleukin 17A (IL-17A), as an inflammatory cytokine, was investigated. In addition to IL-17A, serum levels of interleukin 23 (IL-23) and transforming growth factor β (TGF-β), as effective cytokines in T helper 17 cell (Th17) development, were also determined.</p><p><strong>Method: </strong>Cytokine levels were measured using enzyme-linked immunosorbent assay (ELISA) in healthy subjects with LDL-C<130 versus LDL-C=>130 mg/dL.</p><p><strong>Results: </strong>Although IL-17A is an inflammatory cytokine and a positive association between its levels and LDL-C is expected, the data obtained in this study provide support for a reverse association (<i>p</i><0.05).</p><p><strong>Conclusion: </strong>Inflammation plays a major role in atherosclerosis development; however, various inflammatory components involved in atherosclerosis assert their own unique association with hypercholesterolemia.</p>\",\"PeriodicalId\":10755,\"journal\":{\"name\":\"Current Chemical Genomics and Translational Medicine\",\"volume\":\"12 \",\"pages\":\"1-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-06-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047196/pdf/\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Chemical Genomics and Translational Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/2213988501812010001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Chemical Genomics and Translational Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2213988501812010001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Healthy Adult LDL-C Bears Reverse Association with Serum IL-17A Levels.
Background: Hypercholesterolemia is a modifiable risk factor in atherosclerosis with a complex association with inflammation.
Objective: In the present study, the association between low-density lipoprotein cholesterol (LDL-C) and interleukin 17A (IL-17A), as an inflammatory cytokine, was investigated. In addition to IL-17A, serum levels of interleukin 23 (IL-23) and transforming growth factor β (TGF-β), as effective cytokines in T helper 17 cell (Th17) development, were also determined.
Method: Cytokine levels were measured using enzyme-linked immunosorbent assay (ELISA) in healthy subjects with LDL-C<130 versus LDL-C=>130 mg/dL.
Results: Although IL-17A is an inflammatory cytokine and a positive association between its levels and LDL-C is expected, the data obtained in this study provide support for a reverse association (p<0.05).
Conclusion: Inflammation plays a major role in atherosclerosis development; however, various inflammatory components involved in atherosclerosis assert their own unique association with hypercholesterolemia.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
